Patients Perspective in Plasma Products (Focus on Hemophilia)

Effective treatment of inherited bleeding disorders has become available from plasma in the last 50 years. Plasma-derived medicinal products are used in Iran in a wide variety of clinical problems. Some of these products are manufactured by Iranian Voluntary donor plasma in contract to European pharmaceutical company. The safe preparation of plasma products is important; including screening blood donors, testing plasma for infectious pathogens. A perspective of the World Federation of Hemophilia (WFH) is to increase worldwide supply of safe affordable factor replacement therapy.